IL6 and cancer: Studies have proved that Bazedoxifene inhibits IL‐6/gp130 signalling pathway in several types of cancer,60, 61, 62 but whether the observed benefit of Bazedoxifene intake is dependent of IL‐6 signalling in pressure overload mice has not been established.